ZMC(600216)2019-04-23 16:00Financial Performance - Net profit attributable to shareholders was CNY 132,958,785.09, a decrease of 71.43% year-on-year[10] - Operating revenue for the period was CNY 1,718,620,418.75, down 10.60% from the same period last year[10] - Basic earnings per share decreased to CNY 0.14, down 71.43% from CNY 0.49 in the same period last year[10] - The weighted average return on net assets was 1.73%, a decrease of 4.45 percentage points compared to the previous year[10] - Total operating revenue for Q1 2019 was CNY 1,718,620,418.75, a decrease of 10.6% compared to CNY 1,922,400,190.61 in Q1 2018[45] - Net profit for Q1 2019 was CNY 123,589,689.71, down 73.6% from CNY 467,692,127.69 in Q1 2018[47] - Total profit for Q1 2019 was CNY 144,002,346.92, down 73.0% from CNY 534,245,708.22 in Q1 2018[47] - The company experienced a decrease in comprehensive income, totaling CNY 119,998,336.21 in Q1 2019, down from CNY 486,404,648.96 in Q1 2018[47] - Total comprehensive income for the first quarter of 2019 was CNY 126,032,374.28, compared to CNY 440,942,662.14 in the first quarter of 2018, representing a significant decrease[53] Cash Flow - The net cash flow from operating activities was -CNY 35,624,950.01, an improvement of 76.11% compared to -CNY 149,119,375.92 in the previous year[10] - Cash inflow from operating activities totaled CNY 1,858,261,814.08 in Q1 2019, slightly up from CNY 1,846,391,146.85 in Q1 2018[57] - Cash inflow from investment activities was CNY 539,505,278.79 in Q1 2019, compared to CNY 291,887,589.22 in Q1 2018, indicating a strong increase[57] - Cash inflow from financing activities was CNY 202,098,987.50 in Q1 2019, up from CNY 191,760,000.00 in Q1 2018[59] - The ending balance of cash and cash equivalents was CNY 1,404,398,504.71 at the end of Q1 2019, down from CNY 1,484,876,296.91 at the end of Q1 2018[59] Assets and Liabilities - Total assets at the end of the reporting period reached CNY 10,188,872,810.54, an increase of 1.40% compared to the end of the previous year[10] - The company's total liabilities as of March 31, 2019, were RMB 1.90 billion, slightly up from RMB 1.89 billion at the end of 2018[34] - Total liabilities rose to CNY 1,481,244,918.58 compared to CNY 1,442,255,619.13, an increase of about 2.06%[41] - The company's total equity reached CNY 7,816,213,382.15, up from CNY 7,704,989,950.44, indicating a growth of approximately 1.45%[41] - The total current assets reached CNY 4,245,306,654.15, compared to CNY 3,948,165,981.38, reflecting a growth of approximately 7.53%[40] Shareholder Information - Total number of shareholders at the end of the reporting period is 68,359[16] - The largest shareholder, Xin Chang Chang Xin Investment Development Co., Ltd., holds 208,192,361 shares, accounting for 21.57% of total shares[16] - The company repurchased a total of 6,827,500 shares, accounting for 0.71% of the total share capital, with a total payment of approximately RMB 59.98 million[24] - The company plans to utilize the repurchased shares for equity incentives, as approved in the board meeting[24] Investment and Expenses - Investment income surged by 7458.75%, amounting to 18,443,586.90 RMB, primarily from the sale of stocks[20] - Research and development expenses rose to CNY 64,247,921.28, an increase of 28.8% from CNY 49,866,639.76 in Q1 2018[45] - The company reported a significant increase in financial expenses, totaling CNY 22,482,069.80, compared to CNY 42,773,878.26 in Q1 2018[45] Market Outlook - The company expects a significant decrease in cumulative net profit compared to the same period last year due to a shortage in the vitamin A market and subsequent price fluctuations[27] - The company plans to expand its market presence and invest in new product development, although specific figures were not disclosed[76]